Rocket Lab (RKLB) shares are changing hands at $102.39, marking a 6.50% gain on Monday, driven by a bullish analyst reassessment and the company’s confirmed addition to a major stock index.
Rocket Lab USA, Inc., RKLB
KeyBanc elevated its rating on RKLB to Overweight from Sector Weight while establishing a $135 price target. This valuation implies approximately 40% appreciation potential from current trading levels. The analyst firm maintained its existing financial projections.
The timing of the upgrade aligns with Rocket Lab‘s scheduled entry into the Nasdaq-100 on June 22. Such index additions typically generate buying pressure from over 200 exchange-traded and index funds tracking the benchmark, which manage more than $800 billion in combined assets.
KeyBanc highlighted Rocket Lab’s standing as the number two competitor in the commercial orbital launch industry. The company’s Electron vehicle has achieved approximately 90 successful orbital missions to date.
For many analysts, the Neutron rocket program represents the more significant catalyst. KeyBanc indicated it has developed improved clarity on the program’s status during recent months and verified that a January testing setback has been completely addressed. The Neutron vehicle remains scheduled for its inaugural flight within this calendar year.
Stifel recently boosted its RKLB price objective to $132 from $110 while reaffirming its Buy recommendation, pointing to robust revenue growth and an expanding contract pipeline.
On May 7, Rocket Lab disclosed Q1 revenue totaling $200.35 million, surpassing the $189.65 million Wall Street consensus. This figure represented a 63.4% increase compared to the prior-year quarter.
Earnings per share registered at -$0.07, aligning with analyst expectations. The company recorded a net margin of negative 26.87% alongside a negative return on equity of 11.72%. Full-year EPS is projected at -$0.29 by the analyst community.
Shares have rocketed more than 300% over the trailing twelve months. The stock reached a 52-week peak of $151.00 and touched a low of $25.24, currently trading roughly 24% beneath its recent high. The 50-day moving average stands at $101.62.
Institutional stakeholders control 71.78% of outstanding RKLB shares. During Q1, AQR Capital Management expanded its holdings by more than 100%, purchasing an additional 92,849 shares. NewEdge Advisors boosted its position by over 1,800%. UBS Asset Management acquired 90,758 shares, elevating its total ownership to 773,548.
Entropy Technologies LP grew its stake by 18.5% in Q4, bringing its holdings to 55,117 shares valued at approximately $3.85 million.
Regarding insider transactions, Director Alexander Slusky divested 100,000 shares on May 12 at $118.08, trimming his stake by 18.7%. Insider Marvin Bradford Clevenger sold 15,549 shares on May 26 at $142.57, with the transaction attributed to tax withholding requirements on vested equity compensation.
Wall Street sentiment skews positive overall. Twelve analysts assign a Buy rating, three rate it Strong Buy, five recommend Hold, and one suggests Sell. The average price target among analysts is $102.76.
The equity has also gained from increased investor focus on space industry equities following SpaceX’s recent Nasdaq listing, prompting capital flows into aerospace-related stocks.
The post Rocket Lab (RKLB) Stock Soars 6.5% on KeyBanc Upgrade and Nasdaq-100 Entry Confirmed appeared first on Blockonomi.

